TIMP1 and breast carcinoma: TIMP-1 overexpression has also been observed to decrease expression of progesterone receptor, one of the major receptors in breast cancer cells, and mediate drug resistance in MCF-7 cells37, 38 and promote tumor growth and cell survival39.